Cancer Control Clinical Trials

Narrow List by Age:

(Refer to Clinical Summary for age requirements)

Cancer Control

Protocol COG ACCL1932
Cancer Type: multi-site
Fast Facts

COG-ACCL1932: Letermovir Prophylaxis for Cytomegalovirus in Pediatric Hematopoietic Cell Transplantation

Age:  ≥2 years and <18 years at the time of enrollment

 

Please check out the rare protocol list to locate other studies within this disease site.

Protocol COG ALTE03N1
Cancer Type: Multi-site Cancer Control
Fast Facts

Key Adverse Events After Childhood Cancer

Diagnosis of Primary Cancer at Age 21 or Younger, Irrespective of Current Age.

Please check out the rare protocol list to locate other studies within this disease site.

Cancer clinical trials are research studies for developing better ways of detecting, treating, and eventually preventing cancer. By taking part in a clinical trial, you are among the first to receive new research treatments before they are widely available. Your participation in a clinical trial will influence the future direction of cancer care.

If you are interested in participating in a clinical trial, consult with your physician. Please note: clinical trials are not risk free. Patients must explore the options that are best for their individuals needs with the help of their physician.